₹2,438.30
+₹38.30 (+1.60%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹68,863 Cr
P/E
38.30
ROE
28.08%
ROCE
32.70%
About Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals is engaged in the business of development, manufacturing and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredient to regulated and semi-regulated markets.
Founded
1977
CEO
Glenn Saldanha
Employees
16,623
HQ
Mumbai, India
About Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals is engaged in the business of development, manufacturing and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredient to regulated and semi-regulated markets.
Founded:1977
CEO:Glenn Saldanha
Employees:16,623
HQ:Mumbai, India
Finished Products
1Sales
₹32,033.24Cr2Other Operating Income
₹698.45Cr3Services
₹95.35CrRaw Materials
1Raw Material Consumed
₹2,990.41Cr29 (Dicaboxylic Acid)
₹2,715.79Cr3Purchases of Traded Goods
₹695.99Cr4Stores and Spares
₹65.66CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2,474
52W Low
₹1,793
Volume479.93K
Avg VolumeN/A
Beta0.86
Dividend Yield0.20%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
38.30x
Valuation
P/B Ratio
6.55x
Valuation
EPS
₹63.70
Valuation
Dividend Yield
0.20%
Valuation
ROE
28.08%
Profitability
ROCE
32.70%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical ProductsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
33.7%
International
66.3%
India33.7%
North America22.6%
Europe22.6%
Rest of the World (including Latin21.1%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.06x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
12.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.